- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/64 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
Patent holdings for IPC class C07D 233/64
Total number of patents in this class: 1338
10-year publication summary
|
109
|
97
|
90
|
91
|
85
|
76
|
83
|
100
|
82
|
88
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| ThermoLife International, LLC | 187 |
63 |
| King Faisal University | 936 |
37 |
| Allergan, Inc. | 2146 |
28 |
| Nippon Soda Co., Ltd. | 886 |
24 |
| Janssen Pharmaceutica N.V. | 3142 |
14 |
| Bristol-myers Squibb Company | 4761 |
13 |
| Bayer Pharma AG | 1005 |
13 |
| Centre National de La Recherche Scientifique | 11122 |
12 |
| F. Hoffmann-La Roche AG | 7792 |
11 |
| Allergan Holdings Unlimited Company | 37 |
11 |
| Daiichi Sankyo Company, Limited | 1894 |
11 |
| Takeda Pharmaceutical Company Limited | 2700 |
9 |
| Exelixis, Inc. | 394 |
9 |
| The Rockefeller University | 583 |
9 |
| Lexicon Pharmaceuticals, Inc. | 194 |
8 |
| The Salk Institute for Biological Studies | 452 |
8 |
| Translate bio, Inc. | 416 |
8 |
| Merck Sharp & Dohme LLC | 3734 |
8 |
| Hoffmann-La Roche Inc. | 3849 |
7 |
| The Regents of the University of California | 20924 |
7 |
| Other owners | 1028 |